Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia

被引:0
|
作者
Mengjun Zhong
Rili Gao
Ruocong Zhao
Youxue Huang
Cunte Chen
Kehan Li
Xibao Yu
Dingrui Nie
Zheng Chen
Xin Liu
Zhuandi Liu
Shaohua Chen
Yuhong Lu
Zhi Yu
Liang Wang
Peng Li
Chengwu Zeng
Yangqiu Li
机构
[1] Jinan University,Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology
[2] Chinese Academy of Sciences,Center for Cell Regeneration and Biotherapy, Guangzhou Institutes of Biomedicine and Health
[3] Jinan University,Department of Hematology, First Affiliated Hospital
[4] Jinan University,Department of Oncology, First Affiliated Hospital
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Van Loocke, W.
    Pieters, T.
    Vandamme, N.
    Lintermans, B.
    Dobay, M. P.
    Berx, G.
    Poppe, B.
    Goossens, S.
    Bornhauser, B. C.
    Bourquin, J-P
    Van Vlierberghe, P.
    LEUKEMIA, 2017, 31 (10) : 2037 - 2047
  • [42] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    S Peirs
    V Frismantas
    F Matthijssens
    W Van Loocke
    T Pieters
    N Vandamme
    B Lintermans
    M P Dobay
    G Berx
    B Poppe
    S Goossens
    B C Bornhauser
    J-P Bourquin
    P Van Vlierberghe
    Leukemia, 2017, 31 : 2037 - 2047
  • [43] Current challenges for CAR T-cell therapy of acute myeloid leukemia
    Sauer, Tim
    Rooney, Cliona M.
    TRANSFUSION, 2019, 59 (04) : 1171 - 1173
  • [44] Chimeric antigen receptor T-cell therapy in acute myeloid leukemia
    Koedam, Jan
    Wermke, Martin
    Ehninger, Armin
    Cartellieri, Marc
    Ehninger, Gerhard
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 74 - 83
  • [45] Combined MEK and PD-1 inhibition in acute myeloid leukemia: Effect on cell proliferation and phenotype
    Moshofsky, Kaycee B.
    Cho, Hyun J.
    Kosaka, Yoko
    Newman, Matthew T.
    Tyner, Jeffrey W.
    Lind, Evan F.
    CANCER RESEARCH, 2019, 79 (13)
  • [46] Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy
    Kobold, Sebastian
    Grassmann, Simon
    Chaloupka, Michael
    Lampert, Christopher
    Wenk, Susanne
    Kraus, Fabian
    Rapp, Moritz
    Duewell, Peter
    Zeng, Yi
    Schmollinger, Jan C.
    Schnurr, Max
    Endres, Stefan
    Rothenfusser, Simon
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
  • [47] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Li, Zhuoyan
    Philip, Mary
    Ferrell, P. Brent
    ONCOGENE, 2020, 39 (18) : 3611 - 3619
  • [48] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Zhuoyan Li
    Mary Philip
    P. Brent Ferrell
    Oncogene, 2020, 39 : 3611 - 3619
  • [49] Macrophage instead of leukemia cell expressed PD-L1 drives T cell exhaustion and immune evasion of BCRABL1 chronic myeloid leukemia
    Lu, Xiaocui
    Fang, Hui
    Fang, Xuexiu
    Matsunaga, Atsuko
    Liu, Kebin
    Cortes, Jorge
    Cowell, John K.
    Hu, Tianxiang
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Concomitant presentation of acute myeloid leukemia with T-cell large granular lymphocytic leukemia
    Malani, Ashok Kumar
    Gupta, Chakshu
    Rangineni, Rajgopal
    Singh, Jaswinder
    Ammar, Hussam
    ACTA ONCOLOGICA, 2007, 46 (02) : 247 - 249